Jump to content
PC Security Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    274
  • comment
    1
  • views
    304

Over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry : interestingly, the majority (>55%)


Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).

 

To order this 250+ page report, which features 100+ figures and 140+ tables, please visit this - https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:

§  Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

§  Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

§  Type of Drug Molecule

§  Biologics 

§  Small Molecule

§  Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific

 

The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction
 

4. Market Landscape
 

5. Role of Non-Profit / Academic Organizations

 

6. Company Profiles
 

7.  Partnerships
 

8. Big Pharma Initiatives
 

9. Case Study: Discontinued Drug Development Programs
 

10. Cost Saving Analysis
 

11. Market Forecast and Opportunity Analysis
 

12.  Covid-19 Impact on Drug Repurposing Service Providers Market
 

13. Recent Advancements and Trends in Outsourcing of Drug Repurposing

 

14. Interview Transcripts

 

15. Appendix 1: List of Potential Drug-Indication Candidates for Drug Repurposing

 

16. Appendix 2: Tabulated Data

 

17. Appendix 3: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com 

0 Comments


Recommended Comments

There are no comments to display.

Guest
Add a comment...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
  • Create New...